What Is Clearmind Medicine Inc. (CMND) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Clearmind Medicine Inc. presents a highly debated valuation profile at its current price of $1.99. The composite intrinsic value is estimated at $1.82 (-8.4% average upside), masking a wide model spread between the 2 bullish models and 3 bearish models. Model dispersion is worth noting: Dynamic NAV targets $5.64 (+183.3%), versus First Chicago at $0.19 (-90.4%). This +273.7% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About CMND?
6 of 13 models are currently active for CMND. Of these, 3 models suggest upside while 3 models suggest overvaluation. The Bayesian DCF estimates CMND's intrinsic value at $0.55, implying -72.4% downside from the current price. See which stocks rank higher →
How Does CMND Rank in Pharmaceutical Preparations?
Among 438 Pharmaceutical Preparations stocks, CMND ranks #424 by Quality of Company score. CirclFi's QOC score of 2.0/10 evaluates 32 fundamental signals. A score of 2.0 signals below-average fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Clearmind Medicine Inc.'s positioning within the Pharmaceutical Preparations segment means that patent cliff exposure plays an outsized role in fundamental analysis. The sector's unique characteristics — including orphan drug designation — shape both the opportunity set and risk profile.
Is CMND a Value Trap?
The Value Trap algorithm is not active for CMND. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
6 of 13 models are active for Clearmind Medicine Inc.. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Clearmind Medicine Inc. earns a quality score of 2.0/10. This concerning rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +273.7% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every CMND valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across CMND's 6 active models, average confidence is 2%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad